药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Brompheniramine
Clostebol
The risk or severity of edema formation can be increased when Clostebol is combined with Budesonide.
Brompheniramine
4-Hydroxytestosterone
The risk or severity of edema formation can be increased when 4-Hydroxytestosterone is combined with Budesonide.
Brompheniramine
1-Testosterone
The risk or severity of edema formation can be increased when 1-Testosterone is combined with Budesonide.
Brompheniramine
Bolasterone
The risk or severity of edema formation can be increased when Bolasterone is combined with Budesonide.
Brompheniramine
19-norandrostenedione
The risk or severity of edema formation can be increased when 19-norandrostenedione is combined with Budesonide.
Brompheniramine
Nandrolone phenpropionate
The risk or severity of edema formation can be increased when Nandrolone phenpropionate is combined with Budesonide.
Brompheniramine
Glycerol phenylbutyrate
The therapeutic efficacy of Budesonide can be decreased when used in combination with Glycerol phenylbutyrate.
Brompheniramine
Phenylacetic acid
The therapeutic efficacy of Phenylacetic acid can be decreased when used in combination with Budesonide.
Brompheniramine
Phenylbutyric acid
The therapeutic efficacy of Phenylbutyric acid can be decreased when used in combination with Budesonide.
Brompheniramine
Benzoic acid
The therapeutic efficacy of Benzoic acid can be decreased when used in combination with Budesonide.
Brompheniramine
Alcuronium
The risk or severity of myopathy and weakness can be increased when Alcuronium is combined with Budesonide.
Brompheniramine
Gallamine
The risk or severity of myopathy and weakness can be increased when Gallamine is combined with Budesonide.
Brompheniramine
Atracurium
The risk or severity of myopathy and weakness can be increased when Atracurium is combined with Budesonide.
Brompheniramine
Neosaxitoxin
The risk or severity of myopathy and weakness can be increased when Neosaxitoxin is combined with Budesonide.
Brompheniramine
Pyrantel
The risk or severity of myopathy and weakness can be increased when Pyrantel is combined with Budesonide.
Brompheniramine
Rapacuronium
The risk or severity of myopathy and weakness can be increased when Rapacuronium is combined with Budesonide.
Brompheniramine
Vecuronium
The risk or severity of myopathy and weakness can be increased when Vecuronium is combined with Budesonide.
Brompheniramine
Metocurine
The risk or severity of myopathy and weakness can be increased when Metocurine is combined with Budesonide.
Brompheniramine
Mivacurium
The risk or severity of myopathy and weakness can be increased when Mivacurium is combined with Budesonide.
Brompheniramine
Doxacurium
The risk or severity of myopathy and weakness can be increased when Doxacurium is combined with Budesonide.